Physician profile
William P Mayer
NPI 1437177714
$1,328.89
in general payments reported to CMS, 2019-2025
9 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $105 · 2021: $97.45 · 2022: $112 · 2023: $225 · 2024: $180 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $505.55 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $366.31 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $151.31 | 2019-2021 | |
| Bridgebio Pharma, INC. | $148.00 | 2025 | Attruby |
| Bard Access Systems, INC. | $75.17 | 2019 | |
| Cleerly, INC. | $27.63 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Abbott Laboratories | $24.09 | 2019 | |
| Lundbeck LLC | $16.36 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.